Skip to main content
Top

16-01-2024 | Pacemaker | COMMENTARY

Co-presence of subcutaneous implantable cardioverter-defibrillator and leadless pacemaker in high-risk infection patients: are we out of the woods?

Authors: Gianfranco Mitacchione, Federico Migliore

Published in: Journal of Interventional Cardiac Electrophysiology

Login to get access

Excerpt

Since its inception, transvenous (TV) cardiac implantable electronic devices (CIEDs) have proven significant benefits in terms of quality of life and mortality reduction in patients with cardiac conduction disturbances and/or requiring protection against life-threatening ventricular arrhythmias. Nonetheless, the use of TV pacemakers (PMs) and implantable cardiac defibrillators (ICDs) bear the risk of potential lead-related complications as well as significant concerns regarding local and systemic CIED-related infections. …
Literature
9.
go back to reference Calvagna GM, Valsecchi S. Simultaneous subcutaneous implantable cardioverter-defibrillator and leadless pacemaker implantation for patients at high risk of infection: a retrospective case series report. J Interv Card Electrophysiol. 2023; https://doi.org/10.1007/s10840-023-01684-9. Ahead of print. Calvagna GM, Valsecchi S. Simultaneous subcutaneous implantable cardioverter-defibrillator and leadless pacemaker implantation for patients at high risk of infection: a retrospective case series report. J Interv Card Electrophysiol. 2023; https://​doi.​org/​10.​1007/​s10840-023-01684-9. Ahead of print.
Metadata
Title
Co-presence of subcutaneous implantable cardioverter-defibrillator and leadless pacemaker in high-risk infection patients: are we out of the woods?
Authors
Gianfranco Mitacchione
Federico Migliore
Publication date
16-01-2024
Publisher
Springer US
Published in
Journal of Interventional Cardiac Electrophysiology
Print ISSN: 1383-875X
Electronic ISSN: 1572-8595
DOI
https://doi.org/10.1007/s10840-023-01726-2
Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Medication non-adherence is a major barrier to effective healthcare delivery; half of all patients do not follow their doctor’s recommendations or treatment plan.

Our experts explain the fundamentals with a practical discussion of how to manage non-adherence in two common scenarios: hypertension and asthma control.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine